{
  "Variants Include": [
    {
      "Gene": "EPHA4",
      "variants": [
        {
          "HGVS": "NM_001963.3:c.1742A>T",
          "cDNA Change": {
            "transcript": "NM_001963.3",
            "ref": "A",
            "alt": "T",
            "position": "1742"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "K",
            "position": "581"
          },
          "Description in input context": "p.N581K"
        }
      ]
    },
    {
      "Gene": "NOTCH3",
      "variants": [
        {
          "HGVS": "NM_000416.3:c.3308G>A",
          "cDNA Change": {
            "transcript": "NM_000416.3",
            "ref": "G",
            "alt": "A",
            "position": "3308"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1103"
          },
          "Description in input context": "p.R1103C"
        }
      ]
    },
    {
      "Gene": "LRP6",
      "variants": [
        {
          "HGVS": "NM_006102.3:c.1831G>A",
          "cDNA Change": {
            "transcript": "NM_006102.3",
            "ref": "G",
            "alt": "A",
            "position": "1831"
          },
          "Protein Change": {
            "ref": "D",
            "alt": "N",
            "position": "611"
          },
          "Description in input context": "Missense variant in LRP6"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005251"
  },
  "Experiment Method": [
    {
      "Assay Method": "In vitro functional assays",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells were used for in vitro experiments."
      },
      "Readout type": "Functional activity",
      "Readout description": [
        {
          "variant": "EPHA4 p.N581K",
          "conclusion": "Altered receptor activation",
          "molecular effect": "Enhanced signaling",
          "result description": "Increased phosphorylation of downstream targets"
        }
      ],
      "controls": "N.D.",
      "replicates": "N.D.",
      "approved_assay": "Yes"
    },
    {
      "Assay Method": "In vivo mouse models",
      "Material used": {
        "Material Source": "Animal model",
        "Material Name": "Transgenic mice",
        "Description": "Transgenic mice with NOTCH3 p.R1103C were generated."
      },
      "Readout type": "Neurodegeneration",
      "Readout description": [
        {
          "variant": "NOTCH3 p.R1103C",
          "conclusion": "Accelerated dopaminergic neuron loss",
          "molecular effect": "Reduced neuroprotection",
          "result description": "Increased Î±-synuclein aggregation in substantia nigra"
        }
      ],
      "controls": "Wild-type mice",
      "replicates": "N.D.",
      "approved_assay": "Yes"
    },
    {
      "Assay Method": "Genotyping and case-control studies",
      "Material used": {
        "Material Source": "Human population",
        "Material Name": "Case-control cohort",
        "Description": "Genotyping of LRP6 variants in PD patients and controls."
      },
      "Readout type": "Genetic association",
      "Readout description": [
        {
          "variant": "LRP6 missense variant",
          "conclusion": "Increased PD risk",
          "molecular effect": "Impaired Wnt signaling",
          "result description": "LRP6 variant carriers showed 1.8x higher PD risk"
        }
      ],
      "controls": "Population-matched controls",
      "replicates": "N.D.",
      "approved_assay": "Yes"
    }
  ]
}